Loading organizations...
Asymmetry Capital Management, L.P. was an alternative asset management firm focused on quantitative strategies designed to generate asymmetric returns. It employed proprietary models to identify investment opportunities with disproportionately higher upside potential than downside risk. The firm managed capital with an emphasis on disciplined risk management and a dynamic allocation approach across various markets.
Founded in 2012 by Scott Kay, Asymmetry Capital Management, L.P. emerged from Kay's extensive experience in healthcare investing, spanning over two decades. The firm's inception was driven by the insight that traditional investment approaches often overlook the power of asymmetric risk-reward profiles. Kay's vision was to construct portfolios that could thrive in diverse market conditions by exploiting these imbalances.
Historically, the firm served institutional investors and high-net-worth individuals seeking specialized alternative investment strategies. Asymmetry Capital Management, L.P. aimed to provide a differentiated investment experience, focusing on capital preservation and growth irrespective of broader market trends. However, its SEC registration as an investment adviser was terminated in March 2022.
Asymmetry Capital Management has 4 tracked investments across 2 companies. The latest tracked deal is $60.0M Series C in Dice Therapeutics in August 2021.